MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 22.02.2024
Karuna Therapeutics EBITDA per Share 2011-2026 | KRTX
EBITDA per Share Jährlich Karuna Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.3 | -9.12 | -4.92 | -2.71 | -3.79 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.71 | -13.3 | -6.78 |
EBITDA per Share Vierteljährlich Karuna Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -3.12 | - | -2.48 | -2.16 | -1.96 | - | -1.72 | -1.17 | -1.07 | - | -0.73 | -0.68 | -0.39 | - | -0.43 | -145 | -4.32 K | - | -494 K | -202 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.39 | -494 K | -46.7 K |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M |  USA |
 |
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Adaptimmune Therapeutics plc
ADAP
|
-0.11 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
3.54 | $ 80.34 | - | $ 1.55 B | USA |
 |
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M |  Canada |
 |
Aptorum Group Limited
APM
|
0.34 | $ 0.84 | - | $ 4.58 M |  China |
 |
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | China |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
-0.63 | $ 2.67 | - | $ 150 M | China |
 |
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M |  France |
 |
AlloVir
ALVR
|
-44.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | USA |
 |
BioNTech SE
BNTX
|
62.6 | $ 110.34 | - | $ 27.2 B | Germany |
 |
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.57 | - | $ 8.59 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | USA |
 |
Cabaletta Bio
CABA
|
-62.7 | $ 2.44 | - | $ 2.85 M | USA |
 |
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | USA |
 |
Compugen Ltd.
CGEN
|
-0.41 | $ 1.71 | - | $ 153 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
-0.24 | $ 1.5 | - | $ 281 M | USA |
 |
Aptose Biosciences
APTO
|
0.05 | - | -45.71 % | $ 1.2 M | Canada |
 |
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-8.25 | $ 222.03 | - | $ 5 B |  Danmark |
 |
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | USA |
 |
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
1.33 | $ 41.31 | - | $ 4.26 B | USA |
 |
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-10.2 | - | -6.81 % | $ 3.04 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
1.65 | $ 24.45 | - | $ 2.9 B | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-5.3 | $ 49.7 | - | $ 4.19 B |  Schweiz |
 |
Burford Capital Limited
BUR
|
1.11 | $ 8.97 | - | $ 1.44 B | Britain |
 |
Aridis Pharmaceuticals
ARDS
|
-1.57 | - | 17.91 % | $ 11.1 M | USA |
|
Champions Oncology
CSBR
|
0.45 | $ 6.55 | - | $ 89.5 M | USA |
 |
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | USA |
 |
Athira Pharma
ATHA
|
-2.6 | - | - | $ 269 M | USA |
 |
Athersys
ATHX
|
-0.382 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | USA |
 |
Avenue Therapeutics
ATXI
|
-8.71 | - | -52.27 % | $ 4.45 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.01 | $ 4.22 | - | $ 9.18 B | Israel |
 |
Autolus Therapeutics plc
AUTL
|
-0.92 | $ 1.46 | - | $ 373 M | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
1.01 | $ 14.52 | - | $ 4.49 B | USA |
 |
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | USA |